Search clinical trials for: gp100 antigen

Total 980 results

Emergent BioSolutions

Completed

Universal Influenza A Vaccine in Healthy Adults (EBS-UFV-001)

Human Influenza

Australia
Statens Serum Institut

Completed

A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers (THYB-02)

Tuberculosis

Netherlands
National Cancer Institute (NCI)

Completed

Peptide Vaccination for Patients at High Risk for Recurrent Melanoma

Melanoma

United States
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants (HVTN 135)

HIV Infections

South Africa
Janssen Vaccines & Prevention B.V.
National Institute of Allergy and Infectious Diseases (NIAID); Beth Israel... and other collaborators

Completed

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

Healthy

United States, South Africa, Thailand, Uganda, Rwanda
Foundation for Innovative New Diagnostics, Switzerland
Kenya Medical Research Institute

Not yet recruiting

Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study

Visceral Leishmaniasis
Norwegian Institute of Public Health
University of Oslo

Withdrawn

Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission (COVID-19) at Mass Gathering Events.

Covid19
Centre Hospitalier Universitaire Vaudois

Completed

Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19. (RESTART)

SARS-CoV-2

Switzerland
The University Clinic of Pulmonary and Allergic...
Insitute of Microbiology and Immunology, Faculty of Medicine, University...

Completed

Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19

SARS-CoV-2 Rapid Antigen Test

Slovenia
Tongji University

Unknown

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis

Tuberculosis Infection

China
Ministry of Health, Malaysia

Completed

Impact of Legionella Urine Antigen Testing (LUAT) on the Local Epidemiology and Diagnosis of Legionella Pneumonia

Legionella Pneumophila Pneumonia

Malaysia
Assiut University

Completed

Risk of Malignancy Index and Assiut Scoring Model for Adnexal Malignancy

Risk Malignant Index

Egypt
International AIDS Vaccine Initiative
Massachusetts General Hospital; GlaxoSmithKline; Fred Hutchinson Cancer Research... and other collaborators

Completed

A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults

HIV Infections

United States, Kenya
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Roswell Park Cancer Institute

Withdrawn

Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination

Healthy, no Evidence of Disease
National Institute of Allergy and Infectious Diseases...

Completed

Leprosy Skin Test Antigens Phase 1

Leprosy
Statens Serum Institut

Completed

A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31) (THYB-03)

Tuberculosis
M.D. Anderson Cancer Center

Active, not recruiting

Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Beijing Boren Hospital

Recruiting

Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma

Relapse/Recurrence | T-cell Leukemia/Lymphoma | Refractory T Lymphoblastic Leukemia/Lymphoma

China
Institute of Tropical Medicine, Belgium

Withdrawn

Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International Travelers (JOKA-I)

Fever | Malaria

Belgium
Mach-E B.V.

Completed

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.

Covid19

United States
National Institute of Respiratory Diseases, Mexico

Completed

Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study

Covid19

Mexico
Drägerwerk AG & Co. KGaA

Terminated

Dräger COVID-19 Antigen Test Clinical Performance Study

Covid19

Germany
Lumos Diagnostics
Rapid Pathogen Screening

Completed

Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™) (CoviDx)

Covid19 | SARS-CoV-2

United States
The First Affiliated Hospital of Soochow University

Recruiting

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

China
Yale University

Withdrawn

Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma

Lymphoma, T-Cell, Cutaneous
Bristol-Myers Squibb
National Cancer Institute (NCI)

Withdrawn

Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma

Melanoma (Skin)
National Cancer Institute (NCI)

Terminated

Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma

Stage IV Skin Melanoma | Recurrent Melanoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma

United States
Therma Bright Inc

Recruiting

POC Study to Evaluate the Performance of the AcuVid COVID-19 Rapid Antigen Saliva Test

COVID-19

United States
Vaxess Technologies
ICON plc; Q2 Solutions; Centricity Research

Completed

Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP

Influenza

Canada
University of California, Los Angeles

Completed

Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test

Covid19

United States
Columbia University

Terminated

Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen

Covid19

United States
Sky Medical Supplies & Equipments, LLC

Recruiting

This Trial is a Clinical Performance Validation Study That Will Evaluate the Clinical Agreement of the Sky Medical™ Rapid Antigen Test Comparing the Antigen Rapid Test to RT-PCR

COVID-19 | Sars-CoV-2 Infection

United States
Chinese University of Hong Kong

Recruiting

Urinary Antigen Test for Stretococcus Pneumoniae Serotype Prevalence in Community Acquired Pneumonia

Pneumonia

Hong Kong
Cannabis Research Associates

Not yet recruiting

Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2

Covid19
Children's National Research Institute

Active, not recruiting

Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors (REST)

Solid Tumors

United States
MP Biomedicals, LLC
EDP Biotech

Completed

COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability

COVID-19 | Sars-CoV-2 Infection

United States
E25Bio, Inc.
SCRI Development Innovations, LLC

Completed

A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests

SARS CoV-2

United States
Universidad Miguel Hernandez de Elche
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la... and other collaborators

Unknown

Factors Associated With PSA False Negative and False Positive Results and the Impact on Patient's Health.

Prostate-Specific Antigen /Blood

Spain
Arion Bio
CSSi Life Sciences

Completed

GlowTest COVID-19 Antigen Home Test Kit Usability Study

COVID-19

United States
Arion Bio
CSSi Life Sciences

Completed

GlowTest COVID-19 Antigen Home Test Kit QRI Use Study

Covid 19

United States
Vatic Ltd.

Unknown

Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen

Covid19
Nielsen BioSciences, Inc.

Completed

Candin Safety & Efficacy Study for the Treatment of Warts

Warts | Human Papilloma Virus

United States
GlaxoSmithKline

Terminated

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

Lung Cancer, Non-Small Cell

United States, Australia, Canada, Netherlands, Finland, Taiwan, Czechia, Estonia, Spain, Argentina, Belgium, France, Sweden, Germany, Israel, Italy, Korea, Republic of, Singapore, Ukraine, United Kingdom, Austria, Ireland, Thailand, C... and more
Genentech, Inc.

Completed

A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex

HIV Infections

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA Melanoma

United States
National Institute of Allergy and Infectious Diseases...
Inner-City Asthma Consortium

Completed

Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma (SCSS)

Asthma | Allergy

United States
Walter Reed Army Institute of Research (WRAIR)

Completed

A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

HIV Infections | HIV Seronegativity

United States
Marcus Altfeld, M.D., Ph.D.
GlaxoSmithKline

Completed

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

HIV Infections

United States

Search clinical trials for: gp100 antigen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations